McMaster University Hamilton, Ontario, Canada.
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada; Departments of Pediatrics and Anesthesia, McMaster University, Hamilton, Canada; Centre for Evaluation of Medicine, St Joseph's Healthcare-Hamilton, Canada; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare-Hamilton, Canada.
Pain Physician. 2018 Nov;21(6):E623-E632.
Prescription opioid misuse in Canada has become a serious public health concern and has contributed to Canada's opioid crisis. There are thousands of Canadians who are currently receiving treatment for opioid use disorder, which is a chronic relapsing disorder with enormous impact on individuals and society.
The aim of this study was to compare the clinical and demographic differences between cohorts of patients who were introduced to opioids through a prescription and those introduced to opioids for non-medical purposes.
This was an observational, prospective cohort study.
The study took place in 19 Canadian Addiction Treatment Centres across Ontario.
We included a total of 976 participants who were diagnosed with Opioid Use Disorder and currently receiving methadone maintenance treatment. We excluded participants who were on any other type of prescription opioid or who were missing their 6-month follow-up urine screens. We measured the participants' initial source of introduction to opioids along with other variables using the Maudsley Addiction Profile. We also measured illicit opioid use using urine screens at baseline and at 6-months follow-up.
Almost half the sample (n = 469) were initiated to opioids via prescription. Women were more likely to be initiated to opioids via a prescription (OR = 1.385, 95% CI 1.027-1.866, P = .033). Those initiated via prescription were also more likely to have post-secondary education, older age of onset of opioid use, less likely to have hepatitis C and less likely to have use cannabis. Chronic pain was significantly associated with initiation to opioids through prescription (OR = 2.720, 95% CI 1.998-3.722, P < .0001). Analyses by gender revealed that men initiated by prescription were less likely to have liver disease and less likely to use cannabis, while women initiated by prescription had a higher methadone dose.
This project was limited by its study design being observational in nature; no causal relationships can be inferred. Also, the data did not allow determination of the role that the prescribed opioids played in developing opioid use disorder.
Our results have revealed that almost half of this methadone maintenance treatment (MMT) population has been introduced to opioids through a prescription. Given that the increasing prescribing rates of opioids has an impact on this at-risk population, alternative treatments for pain should be considered to help decrease this opioid epidemic in Canada.
Opioid use disorder, chronic pain relief, methadone maintenance treatment, prescriptions, male, female.
在加拿大,处方类阿片类药物滥用已成为严重的公共卫生问题,并导致了该国的阿片类药物危机。目前有成千上万的加拿大人正在接受阿片类药物使用障碍的治疗,这是一种慢性复发性疾病,对个人和社会都有巨大影响。
本研究旨在比较通过处方引入阿片类药物和非医疗目的引入阿片类药物的患者队列之间的临床和人口统计学差异。
这是一项观察性、前瞻性队列研究。
研究在安大略省的 19 家加拿大成瘾治疗中心进行。
我们共纳入了 976 名被诊断患有阿片类药物使用障碍并正在接受美沙酮维持治疗的患者。我们排除了正在使用任何其他类型的处方类阿片类药物或错过 6 个月随访尿液筛查的患者。我们使用莫德斯利成瘾量表测量了参与者最初引入阿片类药物的来源以及其他变量。我们还在基线和 6 个月随访时使用尿液筛查测量了非法阿片类药物的使用情况。
几乎一半的样本(n=469)是通过处方引入阿片类药物的。女性更有可能通过处方引入阿片类药物(OR=1.385,95%CI 1.027-1.866,P=0.033)。通过处方引入的患者也更有可能接受过高等教育,阿片类药物使用的发病年龄更大,丙型肝炎的发生率更低,且使用大麻的可能性更低。慢性疼痛与通过处方引入阿片类药物显著相关(OR=2.720,95%CI 1.998-3.722,P<0.0001)。按性别分析的结果表明,通过处方引入的男性更不容易患肝病和使用大麻,而通过处方引入的女性则使用更高剂量的美沙酮。
本项目受到其研究设计的限制,因为它本质上是观察性的,不能推断出因果关系。此外,数据无法确定处方类阿片类药物在阿片类药物使用障碍发展中的作用。
我们的研究结果表明,美沙酮维持治疗(MMT)人群中几乎有一半是通过处方引入阿片类药物的。由于阿片类药物处方的增加对这一高危人群产生了影响,因此应考虑使用替代治疗方法来缓解加拿大的阿片类药物流行。
阿片类药物使用障碍、慢性疼痛缓解、美沙酮维持治疗、处方、男性、女性。